References
- Chamilos G, Luna M, Lewis RE, . Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematology 2006; 91: 986–989.
- Singh N, Avery RK, Munoz P, . Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46–52.
- Wheat LJ. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003; 5: 158–166.
- Odabasi Z, Mattiuzzi G, Estey E, . Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199–205.
- Maertens J, Verhaegen J, Lagrou K, . Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604–1610.
- Maertens J, Theunissen K, Verbeken E, . Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004; 126: 852–860.
- Marr KA, Balajee SA, McLaughlin L, . Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641–649.
- Viscoli C, Machetti M, Cappellano P, . False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38: 913–916.
- White PL, Mengoli C, Bretagne S, . Evaluation of Aspergillus PCR protocols for testing serum specimens. J Clin Microbiol 2011; 49: 3842–3845.
- Denning DW, Park, S, Lass-Florl, . 2011. High frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52: 1123–1129.
- Greene R. The radiological spectrum of pulmonary aspergillosis. Med Mycol 2005; 43(Suppl. 1):S147–154.
- Perlin DS. Echinocandin-resistant Candida: molecular methods and phenotypes. Curr Fungal Infect Rep 2011; 5: 113–119.
- Denning, DW. Enchinocandin antifungal drugs. Lancet 2003; 362: 1142–1151.
- Garcia-Effron G, Lee S, Park S, . Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother 2009; 53: 3690–3699.
- Perlin DS. Current perspectives on echinocandin class drugs. Future Microbiol 2011; 6: 441–457.